Precision. Clarity. Confidence.

Thank you for visiting De Facto Diagnostics in booth #115 at the ASHI 52nd Annual Meeting!

​

We appreciate your making the debut of our emerging technologies for molecular surveillance in transplantation research such an overwhelming success!  The interest in NovoSight cfDNA, NovoSight Chimerism, and the Transplant Surveyor software was even better than we hoped, as was the engagement in our Early Access Program.  We look forward to continung our conversations from the conference!